Skip to main content
Livermore
Livermore
ZHEN

Context Capital Management, LLC

SEC CIK
0001301396
Latest filing
Jul 23, 2026

The latest 13F from Context Capital Management, LLC covers Q2 2026 (filed Jul 23, 2026): 423 long positions worth $4.96B. The top 10 holdings make up 25.2% of the portfolio, and the largest is EchoStar CORP at 3.5%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
86
Est. +$1.37B
Added
0
Reduced
10
Est. −$10.5M
Sold out
55
Est. −$833.9M

Top 5 holdings

Share of this quarter's portfolio value

  1. EchoStar CORP278768AB2
    3.5%$172.1M
  2. Makemytrip Limited Mauritius56087FAD6
    3.0%$150.8M
  3. GameStop Corp.36467WAE9
    2.9%$144.6M
  4. Super Micro Computer, Inc.86800UAB0
    2.8%$139.9M
  5. Enovis CORP194014AB2
    2.3%$115.4M

Biggest buys

New and added positions, by estimated amount bought

  1. Makemytrip Limited Mauritius56087FAD6
    +$150.8MNew
  2. GameStop Corp.36467WAE9
    +$144.6MNew
  3. GameStop Corp.36467WAG4
    +$103.3MNew
  4. GOOGMAlphabet Inc.
    +$91.6MNewHistory
  5. GOOGNAlphabet Inc.
    +$88.0MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Makemytrip Limited Mauritius56087FAD6
    +3.04 pp0.0% → 3.0%
  2. GameStop Corp.36467WAE9
    +2.92 pp0.0% → 2.9%
  3. GameStop Corp.36467WAG4
    +2.08 pp0.0% → 2.1%
  4. GOOGMAlphabet Inc.
    +1.85 pp0.0% → 1.8%History
  5. GOOGNAlphabet Inc.
    +1.78 pp0.0% → 1.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CONMED Corp207410AH4
    −$115.9MSold out
  2. Enphase Energy, Inc.29355AAK3
    −$76.4MSold out
  3. Travere Therapeutics, Inc.89422GAA5
    −$66.9MSold out
  4. Ironwood Pharmaceuticals Inc46333XAH1
    −$58.1MSold out
  5. NEE.PVNextera Energy Inc
    −$47.0MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CONMED Corp207410AH4
    −2.68 pp2.7% → 0.0%
  2. Enphase Energy, Inc.29355AAK3
    −1.77 pp1.8% → 0.0%
  3. Travere Therapeutics, Inc.89422GAA5
    −1.55 pp1.5% → 0.0%
  4. Ironwood Pharmaceuticals Inc46333XAH1
    −1.34 pp1.3% → 0.0%
  5. NEE.PVNextera Energy Inc
    −1.09 pp1.1% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$4.96B
+$629.3M (+14.5%) vs. prior quarter
Positions
423
+31 vs. prior quarter
Top 10 concentration
25.2%
Top 10 as share of value
Turnover
18.2%
Q2 2026, one quarter
Average holding period
4.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $4.96B (Q2 2026)

Q1 2021: $1.02BQ2 2021: $1.08BQ3 2021: $979.5MQ4 2021: $1.28BQ1 2022: $1.54BQ2 2022: $1.40BQ3 2022: $1.49BQ4 2022: $1.37BQ1 2023: $1.19BQ2 2023: $1.11BQ3 2023: $1.25BQ4 2023: $1.49BQ1 2024: $2.10BQ2 2024: $2.78BQ3 2024: $3.68BQ4 2024: $2.56BQ1 2025: $2.58BQ2 2025: $2.96BQ3 2025: $3.24BQ4 2025: $3.88BQ1 2026: $4.33BQ2 2026: $4.96B
Q1 2021Q2 2026
13F filings of Context Capital Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 23, 2026423$4.96BEchoStar CORPMakemytrip Limited MauritiusGameStop Corp.vs. Q1 2026SEC
Q1 2026May 7, 2026392$4.33BStrategy IncEchoStar CORPCentury Alum Covs. Q4 2025SEC
Q4 2025Feb 13, 2026327$3.88BStrategy IncEchoStar CORPPeloton Interactive, Inc.vs. Q3 2025SEC
Q3 2025Nov 12, 2025268$3.24BEchoStar CORPBloom Energy CorpPeloton Interactive, Inc.vs. Q2 2025SEC
Q2 2025Aug 6, 2025251$2.96BPeloton Interactive, Inc.Teladoc Health, Inc.CONMED Corpvs. Q1 2025SEC
Q1 2025May 5, 2025208$2.58BCONMED CorpTeladoc Health, Inc.3D Sys Corp Delvs. Q4 2024SEC
Q4 2024Feb 11, 2025238$2.56B3D Sys Corp DelSnap IncTeladoc Health, Inc.vs. Q3 2024SEC
Q3 2024Nov 14, 2024284$3.68BRocket Lab USA, Inc.Peloton Interactive, Inc.Snap Incvs. Q2 2024SEC
Q2 2024Aug 9, 2024222$2.78BSkin 1.250 10/01/26 CVT3D Sys Corp DelWayfair Inc.vs. Q1 2024SEC
Q1 2024May 2, 2024277$2.10BSkin 1.250 10/01/26 CVTPeloton Interactive, Inc.MicroStrategy Incvs. Q4 2023SEC
Q4 2023Feb 16, 2024Amended281$1.49BPeloton Interactive, Inc.Wayfair Inc.Wayfair Inc.vs. Q3 2023SEC
Q3 2023Nov 13, 2023311$1.25BPeloton Interactive, Inc.Wayfair Inc.Wayfair Inc.vs. Q2 2023SEC
Q2 2023Aug 10, 2023315$1.11BPeloton Interactive, Inc.Wayfair Inc.Wayfair Inc.vs. Q1 2023SEC
Q1 2023May 8, 2023346$1.19BRingCentral, Inc.Wayfair Inc.Pegasystems Incvs. Q4 2022SEC
Q4 2022Feb 14, 2023459$1.37BRingCentral, Inc.Peloton Interactive, Inc.DraftKings Inc.vs. Q3 2022SEC
Q3 2022Nov 7, 2022590$1.49BRingCentral, Inc.Peloton Interactive, Inc.Wayfair Inc.vs. Q2 2022SEC
Q2 2022Aug 3, 2022619$1.40BTheravance Biopharma, Inc.Infinera CorpVarex Imaging Corpvs. Q1 2022SEC
Q1 2022May 9, 2022688$1.54BDISH Network CORPTheravance Biopharma, Inc.Sea Ltdvs. Q4 2021SEC
Q4 2021Feb 9, 2022554$1.28B1Life Healthcare IncVarex Imaging CorpDISH Network CORPvs. Q3 2021SEC
Q3 2021Nov 12, 2021473$979.5MVarex Imaging CorpInfinera CorpTheravance Biopharma, Inc.vs. Q2 2021SEC
Q2 2021Aug 17, 2021522$1.08BVarex Imaging CorpInfinera CorpGranite Constr Incvs. Q1 2021SEC
Q1 2021May 17, 2021462$1.02BInfinera CorpRevance Therapeutics, Inc.Retrophin Inc–SEC

13D and 13G filings

Companies where Context Capital Management, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

5 companies, largest stake first.

Companies where Context Capital Management, LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
GOSSGossamer Bio, Inc.13G9.90%48.8M sharesNewJun 9, 20261 filingJun 9, 2026SEC
BIORBiora Therapeutics, Inc.13G9.90%2.99M sharesNewMar 20, 20241 filingMar 20, 2024SEC
THEOBOA Acquisition Corp. II13G8.50%1.24M sharesNewAug 6, 20261 filingAug 6, 2026SEC
GSRVGSR V Acquisition Corp.13G8.20%1.95M sharesNewMay 20, 20261 filingMay 20, 2026SEC
PLMKPlum Acquisition Corp, IV13G5.60%598.0K sharesNewJul 21, 20261 filingJul 21, 2026SEC

Latest filings

14 filings on file made by Context Capital Management, LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Context Capital Management, LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
THEOBOA Acquisition Corp. IIAug 6, 20266:45 PM ET13G8.50%1.24M sharesNewAug 5, 2026SEC
RENEFCartesian Growth Corp IIAug 5, 20263:16 PM ET13G/A0.00%0 shares−5.10 ppfrom 5.10%Below 5%Aug 4, 2026SEC
PLMKPlum Acquisition Corp, IVJul 21, 202611:39 AM ET13G5.60%598.0K sharesNewJul 16, 2026SEC
GOSSGossamer Bio, Inc.Jun 9, 20268:44 AM ET13G9.90%48.8M sharesNewJun 4, 2026SEC
GSRVGSR V Acquisition Corp.May 20, 20264:36 PM ET13G8.20%1.95M sharesNewMay 15, 2026SEC
RENEFCartesian Growth Corp IINov 5, 20251:09 PM ET13G5.10%450.0K sharesNewNov 3, 2025SEC
BYNDBeyond Meat, Inc.Oct 21, 20254:10 PM ET13G/A0.00%0 shares−5.20 ppfrom 5.20%Below 5%Oct 17, 2025SEC
BYNDBeyond Meat, Inc.Oct 20, 20259:47 AM ET13G5.20%20.5M sharesNewOct 15, 2025SEC
OPENOpendoor Technologies Inc.Jul 14, 202510:49 AM ET13G/A0.00%0 shares−5.70 ppfrom 5.70%Below 5%Jun 30, 2025SEC
FACTFACT II Acquisition Corp.Jul 10, 202510:12 AM ET13G/A1.60%300.0K shares−7.80 ppfrom 9.40%Below 5%Jun 30, 2025SEC
BIORBiora Therapeutics, Inc.Jul 10, 20259:51 AM ET13G/A0.50%22.0K shares–Below 5%Jun 30, 2025SEC
FACTFACT II Acquisition Corp.Jun 12, 20251:54 PM ET13G9.40%1.73M sharesNewNov 26, 2024SEC
OPENOpendoor Technologies Inc.May 16, 202512:38 PM ET13G5.70%44.2M sharesNewMay 9, 2025SEC
BIORBiora Therapeutics, Inc.Mar 20, 20246:29 PM ET13G9.90%2.99M sharesNewMar 12, 2024SEC